Home
News
Careers
Contact Us
About EA
EA Evolution
Team Profile
Vision & Values
Board of Directors
Fact sheet
Expertise
Biosimilars Development
Cell Therapy Expertise
Diagnostic Imaging Agent Development
Serving Generic Companies
Experience
Therapeutic Experience
Study Type
Region
Global Presence
Worldwide
Asia Pacific
Europe
America
Services
Bioavailability and Bioequivalence Services (PK/PD)
Clinical Trials Management
Clinical Data Management
Medical Services
Regulatory Affairs
Pharmacovigilance
Central Laboratory
Links
Whitepapers
Brochures
Bioanalytical Method Library
Corporate Brochure
BABE Brochure
CDM Brochure
Clinical Reference Lab Brochure
Russia
WHO
Clinicaltrials.gov
EMA
MHW
KFDA
CTRI
SFDA
Russia
ANVISA
ACRO
CDISC
Eurotrial
Clinserv
EPS
CnR
LKF
FMD
Events
Testimonials
Press Releases Archive
2013
Proud clinical development partner to Piramal Imaging in bringing to market NeuraCeq
TM
, a radiopharmaceutical for PET imaging of plaque in brain of patients evaluated for cognitive impairment due to Alzheimer’s and other causes.
The CFO Institute conferred the Roll of Honor 2013 to Ecron Acunova’s CFO, Mr. Lalit Mahapatra.
Mr. Mahapatra has been named CFO of the year in the M&A category.
2012
Attend Dermatology Clinical End Point Studies talk by D A Prasanna and Nur Jivani Dec 6th 1220-1300 Hrs @ BA-BE Studies Conf at Holiday Inn, International Airport, Mumbai.
'Developing Unique study design for topical products'
Dr. Anand Bidarkar appointed as Vice President of Business development for Ecron Acunova
Klemens Schuette Appointed Managing Director at Ecron Acunova Germany (EAG)
2011
Ecron Acunova becomes CDISC Registered Solution Provider
EA celebrates 25 years of dedicated service
Battling Tough Times: Small CROs can make it!
EA chosen for BioExcellence Award at Bangalore Bio
EA strengthens clinical research presence in Nordic countries by acquiring majority stake in aCROnordic
- Pharmabiz
- Business World
- Pharmalive US
- Frankfurter Rundschau DE
- Informazione IT
- Netherlands News
EA’s short term goal is to become No. 1 Indian CRO
Ecron Acunova adds on stem cell therapy and diabetes centre to conduct studies for global and Indian sponsors
Single-window, predictable framework needed for CRO growth
EA expands its clinical research centre for drug development
- Biospectrum
- Business Line
- Outlook Business
- Pharmabiz
Ecron Acunova acquires stake in SEA CRO and commences direct operation
- Applied Clinical Trials
- Biospectrum
- Business Line
- Pharmabiz
Ecron Acunova CRO and Newcastle University Collaborate in Clinical Research
- BioPortfolio
- Business Wire India
- Business World
- Contract PharmaPharmabiz
- Express Pharma
- Outlook Business
- PBR News
2010
Chulalongkorn University has joined hands with Ecron Acunova CRO to build an even stronger partnership in Thailand
EA eyes US buy in drug safety studies segment
EA expands operations in Bangalore
- Biospectrum
- Telegraph
EA appoints Dr. A.S. Arvind as Strategic Advisor
- Biospectrum
- Pharma Biz
- Business Line
Lalit Mahapatra appointed as Chief Financial Officer at EA
- Express Pharma
- Biospectrum
- Outlook Business
- Telegraph
- Efy
Dr Klaus Wiedey reappointed Managing Director and CEO Europe
- Pharmabiz
- CNBC
- Outlook Business
- Yahoo Finance
- Daily Finance
D A Prasanna appointed as Chairman and Managing Director for Manipal Acunova Limited
- Biospectrum
- Financial Express
- Express India
- Outlook business
Ecron Acunova appoints Balaji Iyengar as Country Manager & CEO, India
- Financial Express
- Outsourcing Pharma
- Biospectrum
- Outlook business
- Rediff
Law on biomedical research soon
inVentiv Clinical Solutions Expands Its Global Alliance With Partnerships in Europe, Asia and Africa
Stempeutics to launch its stem cell based new drug in India by 2012
Dr. Vijayaraghavan, Scientific Advisory Board Member receives “Science Award”
Leave a message
Choose a file
Cancel
Press Releases Archive
Current Press Releases
2013
2012
2011
2010
Submit your email address to start receiving newsletters from Ecron Acunova.
Cancel
Disclaimer
|
Privacy Policy
|
Site Map
